Cargando…
Plasminogen Activator System and Breast Cancer: Potential Role in Therapy Decision Making and Precision Medicine
Shifting from the historical TNM paradigm to the determination of molecular and genetic subtypes of tumors has been a major improvement to better picture cancerous diseases. The sharper the picture is, the better will be the possibility to develop subsequent strategies, thus achieving higher efficac...
Autores principales: | Gouri, Adel, Dekaken, Aoulia, El Bairi, Khalid, Aissaoui, Arifa, Laabed, Nihad, Chefrour, Mohamed, Ciccolini, Joseph, Milano, Gérard, Benharkat, Sadek |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Libertas Academica
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4993165/ https://www.ncbi.nlm.nih.gov/pubmed/27578963 http://dx.doi.org/10.4137/BMI.S33372 |
Ejemplares similares
-
COVID-19 vaccine race: watch your step for cancer patients
por: Fanciullino, Raphaelle, et al.
Publicado: (2020) -
The association between adverse events and outcome under checkpoint inhibitors: Where is the deal?
por: Milano, Gerard, et al.
Publicado: (2020) -
Evidence-based medicine and precision medicine: Complementary approaches to clinical decision-making
por: Chow, Ngai, et al.
Publicado: (2018) -
Precision Medicine: Technological Impact into Breast Cancer Diagnosis, Treatment and Decision Making
por: Tilli, Tatiana Martins
Publicado: (2021) -
Data-driven decision-making for precision diagnosis of digestive diseases
por: Jiang, Song, et al.
Publicado: (2023)